An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
Beijing Geekgene Technology Co., LTD
The First Affiliated Hospital of Xinxiang Medical College
Chengdu Ucello Biotechnology Co., Ltd.
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Jiangsu YaYao Biotechnology Co., Ltd.
Shanghai Tongji Hospital, Tongji University School of Medicine
Fudan University
Qingdao Sino-Cell Biomedicine Co., Ltd.
Suzhou BlueHorse Therapeutics Co., Ltd.
Suzhou BlueHorse Therapeutics Co., Ltd.
Fujian Cancer Hospital
Fujian Cancer Hospital
The Affiliated Hospital of Qingdao University